New CeMM Principal Investigator Laura de Rooij
On September 1, 2022, Laura de Rooij joined CeMM as a new Principal Investigator. Laura de Rooij will combine wet and dry lab biology to decipher the role of circulating endothelial cells (CECs) in human blood. Her research will advance the understanding and highlight the potential of this cell type in the treatment of age-associated diseases, expanding, thus, CeMM’s expertise in the field of aging. The rare circulating endothelial (progenitor)…
SMNDC1 loss induces alpha cells to produce insulin
Beta cells in the pancreas are responsible for producing the vital hormone insulin. In diabetes, these cells are either destroyed or functionally impaired, resulting in elevated blood sugar levels in the body. Researchers led by Principal Investigator Stefan Kubicek at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, have now shown that alpha cells, which are also located in the pancreas, can be stimulated to…
RESOLUTE and REsolution provide new resources to empower research on human transporters
Humans need to eat to survive. Our cells acquire nutrients from food, such as vitamins, sugars and proteins, to grow, duplicate and exert their functions. But how do these nutrients enter our cells? Solute carriers (SLCs in short) are proteins that are located on cell membranes and regulate the traffic of all kind of chemical matter. They constitute the largest family of transporters in the human genome and are associated with many diseases,…
Receptor FIBCD1 newly identified in neuro-developmental disorders
A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder. Using data from two young patients with neurological symptoms, the researchers from both groups found evidence of a novel function for the FIBCD1 gene in the brain, and a potentially pivotal role in diseases such as…
Study confirms accuracy of national virus variant monitoring of wastewater
Since 2020, Austria has played an internationally pioneering role in monitoring the COVID-19 pandemic by sequencing virus particles from wastewater samples. A recent study by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Medical University of Vienna, the University of Innsbruck, and many other collaboration partners now demonstrates unprecedented detail and accuracy when it comes to analyses of how…
CeMM Adjunct PI Joanna Loizou will join AstraZeneca
Joanna Loizou, one of the Principal Investigators who helped establish CeMM from 2011 to 2020, is leaving Vienna to join AstraZeneca. After her full engagement at CeMM, in 2020 Joanna Loizou became group leader at the Medical University of Vienna while remaining a CeMM Adjunct PI. CeMM congratulates Joanna on her new position as Director in the Translational Medicine Department at AstraZeneca in Cambridge, UK. After her significant fundamental…
2nd REsolution Consortium Meeting
On 20 June 2022, the REsolution consortium held its second consortium meeting, which was the first one in person since the project started. The event took place at CeMM with 20 participants coming from different countries. The REsolution consortium is a public-private research partnership supported by the Innovative Medicines Initiative (IMI), the European Union and EFPIA, with nine partners from academia and the pharmaceutical industry. With a…
Catalyst from hot water
The research group of chemist Miriam Unterlass, CeMM Adjunct Principal Investigator and professor the University of Konstanz, succeeded in producing organic and inorganic substances in a single process using an environmentally friendly method. The production of chemical substances normally requires environmentally harmful solvents. After the research group of Miriam Unterlass, professor of Solid State chemistry at the University of Konstanz and…
Christoph Bock received the prestigious Erwin Schrödinger Award of the Austrian Academy of Sciences
CeMM congratulates Principal Investigator Christoph Bock on being awarded the Erwin Schrödinger Award of the Austrian Academy of Sciences (ÖAW) for his pioneering achievements in the field of single-cell sequencing and epigenetics. The Erwin Schrödinger Award together with the Wilhelm Hartel Prize are the highest prizes awarded annually by the ÖAW. Epigenetics have been one of the main interests of bioinformatician Christoph Bock’s biomedical…
New CeMM Principal Investigator André Rendeiro
On 1 June 2022, André Rendeiro joins CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, as new Principal Investigator. André Rendeiro will employ computational approaches to understand human aging from a molecular, cellular and tissue level to the individual and population scale. His group will contribute to expanding CeMM’s expertise in the field of spatial and computational biology. André Rendeiro studied…
CeMM 15th Anniversary Symposium
On 20-21 May 2022, CeMM hosted the Scientific Anniversary Symposium on the occasion of the 15th anniversary of our institute. The conference on “Molecular medicine from signal transduction to societal impact: A journey through challenging territories” included an exciting line-up of renowned speakers working in the field of molecular biology across Europe and overseas. During the two-day event, 300 participants from the international scientific…
15th CeMM Landsteiner Lecture by Wendell Lim and the 2021 Denise P. Barlow Award Ceremony
On 9 May 2022, CeMM hosted the 15th Landsteiner Lecture with keynote speaker Wendell Lim, Professor and Chair of the Department of Cellular and Molecular Pharmacology at the University of California San Francisco (USA), and Director of the Nanomedicine Development Center and the Synthetic Biology Engineering Research Center. The event opened with the first piece of the famous set “3 Old Viennese Dances”, composed by Austrian-American violinist…
CeMM Research Report 2021
RESEARCH FORTE is used to create knowledge and awareness. This particular package contains information and data about humans and their health. It is a research concentrate of science. Behind every medical treatment and any pharmaceutical pill, no matter how small and simple-looking, there is a mountain of research. Look inside the box and see what's inside RESEARCH FORTE. Please read the package insert carefully! Discover the CeMM Research…
Time for Change: CeMM unveils new corporate identity
At CeMM, we are constantly evolving and growing, always striving to improve ourselves and our research in line with the latest scientific research discoveries. With a modern and fresh new look, and a dedicated claim, we wish to take up the new challenges of our time and continue our path of medical innovation and discovery. After 15 years of pioneering work, we want to see our achievements, our constant development, our innovations in medicine…
CeMM Scientific Recess 2022
After two years of pandemic, CeMM had the chance again to organize in person its annual Scientific Recess, from 4 to 6 April 2022, in Windischgarsten, a beautiful location surrounded by nature in Upper Austria. This year’s main goal was to offer a space for CeMM colleagues to reconnect with one another and find out more about their research work. Following all health and safety measures, a group of 60 colleagues representing all CeMM groups and…
